#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11758	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2058	564.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1671	1671	T	637	T,C,G	612,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11758	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2058	564.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1405	1405	C	687	C	670	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21862	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3480	622.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1617	1617	A	725	A,G	705,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21862	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3480	622.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2251	2251	C	689	C,T,A	662,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21862	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3480	622.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2325	2325	A	653	A,C	633,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21862	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3480	622.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2877	2877	C	662	C	645	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	21862	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3480	622.7	0	HET	.	.	.	C1005T	.	1005	1005	C	1285	1285	C	694	C,T	525,150	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	96190	blaTEM	861	861	100.0	blaTEM.l15.c30.ctg.1	1542	5432.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	539	1576	folP	855	855	99.77	folP.l15.c4.ctg.1	1643	95.3	0	.	p	.	0	A81V	NONSYN	241	243	GCG	614	616	GTG	126;125;127	G;T,G;G	122;109,1;123	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	539	1576	folP	855	855	99.77	folP.l15.c4.ctg.1	1643	95.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1058	1060	AGC	152;152;156	A;G;C	149;149;153	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3324	132.5	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	166;165;168	T;T,C;C	163;161,1;163	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3324	132.5	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	155;153;154	G;G,A;C,T	151;148,1;149,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4442	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3324	132.5	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	155;153;154	G;G,A;C,T	151;148,1;149,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1354	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1281	105.1	1	SNP	p	G45D	0	.	.	133	135	GGC	480	482	GGC	158;158;157	G;G,A;C	153;151,1;152	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	746	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	946	77.8	0	.	n	.	0	A197.	DEL	197	197	A	516	516	A	179	A	172	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	0	.	p	.	0	E91G	NONSYN	271	273	GAG	575	577	GGG	146;146;147	G;G,A;G	142;141,1;142	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	1	SNP	p	D86N	0	.	.	256	258	GAC	560	562	GAC	154;152;151	G;A;C	147;147;149	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	1	SNP	p	S87W	0	.	.	259	261	AGT	563	565	AGT	151;151;150	A;G;T	147;147;142	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	1	SNP	p	S87R	0	.	.	259	261	AGT	563	565	AGT	151;151;150	A;G;T	147;147;142	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	1	SNP	p	S87I	0	.	.	259	261	AGT	563	565	AGT	151;151;150	A;G;T	147;147;142	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	3906	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2949	131.1	1	SNP	p	S88P	0	.	.	262	264	TCC	566	568	TCC	147;147;147	T;C;C	142;144;143	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3392	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2633	127.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	153;147;145	G;G;C,G	150;143;139,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1242	1244	GCA	177;176;176	G;C;A,C	169;168;167,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1245	1247	ATC	174;173;172	A,C;T;C	166,1;166;165	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1257	1259	GTG	170;170;170	G;T;G	164;158;166	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1257	1259	GTG	170;170;170	G;T;G	164;158;166	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1761	1763	ACC	139;138;138	A;C;C	130;130;129	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1815	1817	GCG	127;132;136	G;C,G;G,C	117;111,3;124,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1815	1817	GCG	127;132;136	G;C,G;G,C	117;111,3;124,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1938	1940	GGC	106;101;98	G,T;G;C	102,1;96;93	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1947	1949	GGC	92;91;92	G;G;C	88;88;90	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3268	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2454	132.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1965	1967	CTG	91;92;90	C,G;T,C,G;G,C	79,5;79,1,1;80,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4766	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3089	152.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1647	1649	CCG	188;189;187	C;C,T;G,A	177;185,1;177,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1982	porA	1146	1146	99.65	porA.l6.c30.ctg.1	1952	100.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	121	C	112	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	0	.	p	.	0	A26T	NONSYN	76	78	GCC	264	266	ACC	203;201;201	A,G;C;C	193,1;193;193	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	0	.	p	.	0	D41K	NONSYN	121	123	GAC	309	311	AAA	194;196;196	A;A;A	191;193;193	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	546	548	AAG	184;182;185	A;A;G	176;178;180	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	0	.	p	.	0	D121G	NONSYN	361	363	GAC	549	551	GGC	185;183;182	G;G;C	179;178;174	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	0	.	p	.	0	V215A	NONSYN	643	645	GTT	831	833	GCT	174;172;171	G;C;T	169;169;168	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2344	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1378	167.7	0	.	p	.	0	A256T	NONSYN	766	768	GCA	954	956	ACA	180;179;181	A;C;A	172;172;173	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8150	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4834	167.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2027	2029	AAT	169;170;170	A;A;T	165;166;164	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	874	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1086	79.9	1	SNP	p	V57M	1	.	.	169	171	ATG	571	573	ATG	171;171;171	A;T;G,A	168;167;165,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	10972	tetM	1920	1920	100.0	tetM.l15.c17.ctg.1	2470	439.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
